ClinicalTrials.Veeva
Menu

Find clinical trials for Endometrial Cancer in Paris, Île-de-France

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Ovarian Cancer
Non-Small-Cell Lung Carcinoma
Breast Cancer
Cancer
Colorectal Cancer
Uterine Cervical Cancer
Triple Negative Breast Cancer

Endometrial Cancer trials near Paris, Île-de-France, FRA:

Refining Adjuvant Treatment in Endometrial Cancer Based on Molecular Features (RAINBO)

The RAINBO umbrella program consists of four clinical trials investigating new adjuvant therapies in endometrial cancer patients. E ...

Enrolling
Endometrial Cancer
Radiation: Vaginal brachytherapy
Drug: Megestrol Acetate

Phase 2, Phase 3

Leiden University Medical Center (LUMC)

Villejuif, France and 13 other locations

This is a Phase III, 2-arm, randomized, open label, multicenter, global study assessing the efficacy and safety of puxitatug samrotecan compared to p...

Enrolling
Endometrial Cancer
Malignant Solid Tumour
Drug: Puxitatug Samrotecan
Drug: Paclitaxel

Phase 3

AstraZeneca
AstraZeneca

Paris, France and 293 other locations

This is a multicenter, open-label, nonrandomized, Phase 2 umbrella study of retifanlimab in participants who have advanced or metastatic endometrial...

Active, not recruiting
Endometrial Cancer
Drug: INCAGN02385
Drug: pemigatinib

Phase 2

Incyte
Incyte

Paris, France and 66 other locations

study to evaluate the efficacy and safety of dostarlimab versus carboplatin-paclitaxel in patients with MMR deficient relapse or advanced endometrial...

Active, not recruiting
Endometrial Cancer
Drug: Carboplatin-Paclitaxel
Drug: Dostarlimab

Phase 3

ARCAGY/ GINECO GROUP

Paris, France and 100 other locations

DESTINY-Endometrial01 will investigate the efficacy of first-line T-DXd + rilvegostomig (Arm A) and/or T-DXd+ pembrolizumab (Arm B) when com...

Enrolling
Endometrial Cancer
Drug: Carboplatin
Drug: Paclitaxel

Phase 3

AstraZeneca
AstraZeneca

Paris, France and 245 other locations

Researchers are looking for new ways to treat people with endometrial cancer (EC) who have previously received treatment with plati...

Active, not recruiting
Endometrial Cancer
Drug: Paclitaxel
Drug: Rescue medications

Phase 3

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Paris, France and 242 other locations

The RAINBO program is a studies group which proposes personalized treatment of patients suffering from endometrial cancer according...

Enrolling
Endometrial Cancer
p53abn
Drug: Olaparib (300 mg BID)

Phase 3

Gustave Roussy

Paris, France and 14 other locations

amount of human epidermal growth factor receptor 2 (HER2) in their tumor sample.In Cohort 1, the main goal is to assess how well BNT323 (als...

Enrolling
Endometrial Cancer
Drug: Doxorubicin
Drug: Docetaxel

Phase 3

BioNTech
BioNTech

Paris, France and 111 other locations

The goal of this clinical study is to find out how the study drug, sacituzumab govitecan (SG) works in participants with endometrial cancer...

Active, not recruiting
Endometrial Cancer
Drug: Paclitaxel
Drug: Sacituzumab govitecan-hziy

Phase 3

Gilead Sciences
Gilead Sciences

Paris, France and 188 other locations

non-resectable metastatic or locally advanced non-colorectal and non-endometrial cancers compared to the standard of care chemother...

Enrolling
Soft Tissue Sarcoma
Adrenocortical Carcinoma
Drug: Dostarlimab
Drug: Chemotherapy

Phase 2

Unicancer
Unicancer

Paris, France and 21 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems